Total Temporomandibular Joint Replacement System
BIOMET MICROFIXATION, INC · Decision date Jul 27, 2026
What did the FDA approve?
FDA records P020016/S010 as a supplement to PMA P020016, with the supplement type “Normal 180 Day Track No User Fee”. The recorded decision is approval, dated Jul 27, 2026.
FDA approval order statement
APPROVAL FOR PROPOSED LABELING CHANGES FOLLOWING THE CONCLUSION OF THE POSTMARKET SURVEILLANCE STUDY FOR THE TOTAL TEMPOROMANDIBULAR JOINT REPLACEMENT SYSTEM.
- Regulatory pathway
- PMA supplement
- Supplement type
- Normal 180 Day Track No User Fee
- Clinical specialty
- Dental
- Decision date
- Jul 27, 2026
- FDA change category
- Labeling Change - PAS
Regulatory record facts
- Identifier
- P020016/S010
- Regulatory pathway
- PMA supplement
- Applicant
- BIOMET MICROFIXATION, INC
- Product code
- Not reported
- Decision code
- APPR
- Decision date
- Jul 27, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
- Applicant
- BIOMET MICROFIXATION, INC
- Product code
- Not reported
Review the original FDA PMA listing for the original approval scope and linked supplements.
FDA decision timeline
P020016/S010 received
Application receipt date recorded by FDA.
P020016/S013 · Related supplement
Total Temporomandibular Joint Replacement System
P020016/S010 · FDA decision
Normal 180 Day Track No User Fee
Timeline entries are records held by MedtechLedger for P020016. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P020016
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
Total Temporomandibular Joint Replacement SystemP020016/S013 | BIOMET MICROFIXATION, INC | PMA supplement | Feb 19, 2026 | FDA |
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
BIOMET MICROFIXATION, INC
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 1520 Tradeport Dr., Jacksonville, FL, 32218
Sources and methodology
- Original FDA record: P020016/S010
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 21, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records